PATIENT INFORMED CONSENT FOR CLINICAL RESEARCH 
Title: A PILOT STUDY OF IMMUNIZATION WITH HLA-A2 MATCHED 
ALLOGENEIC RENAL CELL CARCINOMA CELLS THAT HAVE 
BEEN ALTERED TO SECRETE INTERLEUKIN-2 IN PATIENTS WITH 
RENAL CELL CARCINOMA. 
Purpose: The purpose of this research study is to evaluate the toxicity and safety of 
these specially altered renal carcinoma cells in patients with renal cell 
carcinoma. 
STATEMENT OF PHYSICIAN OBTAINING INFORMED CONSENT 
I have fully explained this research study to the patient or guardian 
. In my judgment, and the patient’s, there 
was sufficient access to information, including risks and benefits, to make an 
informed decision. 
PHYSICIAN’S SIGNATURE 
PHYSICIAN’S NAME 
(Print) 
DATE 
PATIENT’S (OR GUARDIAN’S) STATEMENT 
I have read the description of the clinical research study or have had it translated 
into language I understand. I have also discussed it with the doctor to my 
satisfaction. I understand that 
my/ the patient’s participation is voluntary. I know enough about the purpose, 
methods, risks and benefits of the research study to judge that I (the patient) want 
to take part in it. 
PATIENT NUMBER 
PATIENT SIGNATURE 
[942] 
Recombinant DNA Research, Volume 15 
